Skip to main content

Table 3 Details of SMN1 or SMN2 copy number groups

From: SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan

SMN1:SMN2

copies

Control

(n = 399)

ALS

(n = 487)

LMND

(n = 50)

Control vs. ALS

OR (95% CI)

Control vs. LMND

OR (95% CI)

1:1

3 (0.8%)

1 (0.2%)

0

0.27 (0.02–1.83)

-

1:2

1 (0.3%)

3 (0.6%)

0

2.46 (0.37-32.0)

-

1:3

1 (0.3%)

0

0

-

-

2:0

14 (3.5%)

29 (6.0%)

4 (8.0%)

1.74 (0.90–3.28)

2.39 (0.83–7.33)

2:1

103 (25.8%)

168 (34.5%)

13 (26.0%)

1.51 (1.13–2.03)*

1.01 (0.51-2.00)

2:2

242 (60.7%)

254 (52.2%)

29 (58.0%)

0.70 (0.54–0.93)*

0.90 (0.50–1.62)

2:3

5 (1.3%)

7 (1.4%)

1 (2.0%)

1.15 (0.40–3.22)

1.61 (0.13–12.1)

3:0

4 (1.0%)

3 (0.6%)

1 (2.0%)

0.61 (0.15–2.29)

2.02 (0.16–12.5)

3:1

17 (4.3%)

16 (3.3%)

1 (2.0%)

0.76 (0.40–1.57)

0.46 (0.04–2.76)

3:2

7 (1.8%)

3 (0.6%)

0

0.35 (0.10–1.24)

-

4:0

1 (0.3%)

3 (0.6%)

1 (2.0%)

2.47 (0.37–32.1)

8.12 (0.42–154.5)

4:2

1 (0.3%)

0

0

-

-

  1. * P<0.05